Prediction of postoperative clinical outcomes in resected stage I non-small cell Lung cancer focusing on the preoperative glasgow prognostic score

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Cancers, 12, 1, S. 152-

Event: Veröffentlichung

(where): Augsburg

(who): Universität Augsburg

(when): 2020

Event: Veröffentlichung

(who): MDPI AG

(when): 2020

Creator: Lindenmann, Joerg
Fink-Neuboeck, Nicole
Taucher, Valentin
Pichler, Martin
Posch, Florian
Brcic, Luka
Smolle, Elisabeth
Koter, Stephan
Smolle, Josef
Smolle-Juettner, Freyja Maria

DOI: 10.3390/cancers12010152

URN: urn:nbn:de:bvb:384-opus4-1016955

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lindenmann, Joerg
Fink-Neuboeck, Nicole
Taucher, Valentin
Pichler, Martin
Posch, Florian
Brcic, Luka
Smolle, Elisabeth
Koter, Stephan
Smolle, Josef
Smolle-Juettner, Freyja Maria
Universität Augsburg
MDPI AG

Time of origin

2020

Other Objects (12)

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

The prognostic long-term impact of chronic obstructive pulmonary disease and postoperative mucostasis in patients with curatively resected non-small cell lung cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Liquid biopsy in non-small cell lung cancer: current status and future outlook—a narrative review

Current knowledge about mechanisms of drug resistance against ALK inhibitors in non-small cell lung cancer

The biological and clinical relevance of Inhibitor of Growth (ING) genes in non-small cell lung cancer

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

The prognostic long-term impact of chronic obstructive pulmonary disease and postoperative mucostasis in patients with curatively resected non-small cell lung cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Liquid biopsy in non-small cell lung cancer: current status and future outlook—a narrative review

Current knowledge about mechanisms of drug resistance against ALK inhibitors in non-small cell lung cancer

The biological and clinical relevance of Inhibitor of Growth (ING) genes in non-small cell lung cancer

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

The prognostic long-term impact of chronic obstructive pulmonary disease and postoperative mucostasis in patients with curatively resected non-small cell lung cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Liquid biopsy in non-small cell lung cancer: current status and future outlook—a narrative review

Current knowledge about mechanisms of drug resistance against ALK inhibitors in non-small cell lung cancer

The biological and clinical relevance of Inhibitor of Growth (ING) genes in non-small cell lung cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Prediction of postoperative clinical outcomes in resected stage I non-small cell Lung cancer focusing on the preoperative glasgow prognostic score

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

The prognostic long-term impact of chronic obstructive pulmonary disease and postoperative mucostasis in patients with curatively resected non-small cell lung cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Liquid biopsy in non-small cell lung cancer: current status and future outlook—a narrative review

Current knowledge about mechanisms of drug resistance against ALK inhibitors in non-small cell lung cancer

The biological and clinical relevance of Inhibitor of Growth (ING) genes in non-small cell lung cancer

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

The prognostic long-term impact of chronic obstructive pulmonary disease and postoperative mucostasis in patients with curatively resected non-small cell lung cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Liquid biopsy in non-small cell lung cancer: current status and future outlook—a narrative review

Current knowledge about mechanisms of drug resistance against ALK inhibitors in non-small cell lung cancer

The biological and clinical relevance of Inhibitor of Growth (ING) genes in non-small cell lung cancer

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

The prognostic long-term impact of chronic obstructive pulmonary disease and postoperative mucostasis in patients with curatively resected non-small cell lung cancer

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Liquid biopsy in non-small cell lung cancer: current status and future outlook—a narrative review

Current knowledge about mechanisms of drug resistance against ALK inhibitors in non-small cell lung cancer

The biological and clinical relevance of Inhibitor of Growth (ING) genes in non-small cell lung cancer

Related objects

Reset password